Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Molecular Cancer Therapeutics|July 1, 2010
Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Fabienne Baffert, Catherine H Régnier, Alain De Pover, et al.Journal of Medicinal Chemistry|March 4, 2026
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI DisrupterMarkus Vögtle, Holger Sellner, Emilie Chapeau, et al.ACS Chemical Biology|April 24, 2024
mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1BGregor S Cremosnik, Yannick Mesrouze, Patrik Zueger, et al.Chemmedchem|March 29, 2023
Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP-TEAD Protein-Protein Interaction InhibitorsHolger Sellner, Emilie Chapeau, Pascal Furet, et al.Molecular Cancer Therapeutics|December 23, 2011
Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitorSauveur-Michel Maira, Sabina Pecchi, Alan Huang, et al.Nature Cancer|April 2, 2024
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancersEmilie A Chapeau, Laurent Sansregret, Giorgio G Galli, et al.New Biotechnology|October 19, 2010
"4D Biology for health and disease" workshop reportJan-Pieter Abrahams, Rolf Apweiler, Rudi Balling, et al.Pageof 6